Scott A. Gangloff, SVP, Development & Mfrg at Oncobiologics Inc, holds 26.35K shares in Akero Therapeutics (Ticker: AKRO), holds 78.57K shares in Oncobiologics Inc (Ticker: ONSIU), holds 78.57K shares in Outlook Therapeutics (Ticker: OTLK).
What is the percentage of profitable transactions made by Scott A. Gangloff?
The percentage of profitable transactions made by Scott A. Gangloff is 100%.
What is the average return per transaction made by Scott A. Gangloff?
The average return per transaction made by Scott A. Gangloff is 37.50%.
What stocks does Scott A. Gangloff hold?
Scott A. Gangloff holds: ONSIU, AKRO, OTLK stocks.
What was Scott A. Gangloff’s latest transaction?
Scott A. Gangloff latest transaction was an Uninformative Buy of $51.01K.
What was Scott A. Gangloff's most profitable transaction?
Scott A. Gangloff’s most profitable transaction was an Informative Sell of OTLK stock on November 14, 2016. The return on the trade was 65.90%.
What is Scott A. Gangloff's role in Oncobiologics Inc?
Scott A. Gangloff's role in Oncobiologics Inc is SVP, Development & Mfrg.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.